Schooner Financial Associates

AllianceBernstein (AB) is a global investment firm committed to delivering better outcomes for clients through a diverse and collaborative culture that encourages innovative thinking. The firm serves a wide range of investors, from individual clients to some of the world's largest institutions, while continually seeking alpha across various asset classes. AB emphasizes its dedication to responsible investing, incorporating environmental stewardship, social responsibility, and corporate governance into its strategies. With a focus on innovation, the firm has recently appointed Andrew Chin as its first Chief Artificial Intelligence Officer to enhance its investment research and operational procedures. Generated from the website

Inotek Pharmaceuticals is a privately held biotechnology company based in Lexington, MA, specializing in the discovery and development of innovative treatments for serious ocular diseases. With a robust pipeline focusing on conditions such as glaucoma and age-related macular degeneration, the company employs a scientifically rigorous approach to advance its lead drug candidate, trabodenoson INO-8875, which effectively addresses elevated intraocular pressure. The firm is supported by an experienced management team with a proven track record of successful New Drug Applications (NDAs), aiming to bring its clinical programs to commercialization. In addition to its advanced drug development platform, Inotek offers a range of effective, over-the-counter eye drops for glaucoma, ensuring high-quality products through collaboration with official suppliers and manufacturers. Generated from the website